Culture
Novartis, Novo Nordisk drug flops will likely ‘pop a hole in the The back-to-back failures of cardiovascular drugs from Novartis and Novo Nordisk made headlines.
The back-to-back failures of cardiovascular drugs from Novartis and Novo Nordisk made headlines.
Dr. Kai NakamuraChief Science CorrespondentPublished Sep 11, 2026 at 6:10 AM EDT · 1 min read
Novartis, Novo Nordisk drug flops will likely ‘pop a hole in the The back-to-back failures of cardiovascular drugs from Novartis and Novo Nordisk made headlines. The back-to-back failures of cardiovascular drugs from Novartis and Novo Nordisk made headlines.
Continue reading
Latest →Corrections, sourcing and article labels are part of the publication record. See our editorial standards.